Active ingredientPhenprocoumonCat. No. P-P086-001CAS 435-97-2Family · Pharmaceutical analytical standards
Phenprocoumon
A coumarin anticoagulant and vitamin K antagonist, developed in 1953 by the team of chemist Alfred Winterstein and patented in 1955, decades before the direct factor Xa inhibitors that came into use around 2010. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It stays in the body for a long time: its average half-life is about 150 hours, six to seven days, compared with about 40 for warfarin, and it takes about four weeks for its blood levels to reach a steady state.
Go to the active ingredient →Active ingredientPhenprocoumonCat. No. P-P086-001CAS 435-97-2
Active ingredientPhenprocoumon SulfateCat. No. P-P086-002
Isotopically labelledPhenprocoumon-d5Cat. No. P-P086-004CAS 121513-38-0
Impurity(1-Bromopropyl)benzeneCat. No. P-P086-005CAS 2114-36-5
Impurity(R)-PhenprocoumonCat. No. P-P086-006CAS 5999-27-9
Impurity(S)-PhenprocoumonCat. No. P-P086-007CAS 3770-63-6
Impurity1-(2-Hydroxyphenyl)-3-phenylpentan-1-oneCat. No. P-P086-008CAS 93651-85-5
Impurity4'-Hydroxy PhenprocoumonCat. No. P-P086-009
ImpurityPhenprocoumon Impurity 1Cat. No. P-P086-010CAS 15074-20-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.